These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 21988672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M, Tarnow I, Michelson AD, Jorsal A, Frelinger AL, Parving HH, Rossing P, Tarnow L.
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Tarnow L, Astrup AS, Parving HH.
    Scand J Clin Lab Invest Suppl; 2005; 240():73-9. PubMed ID: 16112962
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.
    Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM.
    Diabetologia; 2008 Nov; 51(11):2100-7. PubMed ID: 18719882
    [Abstract] [Full Text] [Related]

  • 11. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early pregnancy angiogenic markers and spontaneous abortion: an Odense Child Cohort study.
    Andersen LB, Dechend R, Karumanchi SA, Nielsen J, Joergensen JS, Jensen TK, Christesen HT.
    Am J Obstet Gynecol; 2016 Nov; 215(5):594.e1-594.e11. PubMed ID: 27287686
    [Abstract] [Full Text] [Related]

  • 16. IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy.
    Hjortebjerg R, Tarnow L, Jorsal A, Parving HH, Rossing P, Bjerre M, Frystyk J.
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3032-40. PubMed ID: 26046968
    [Abstract] [Full Text] [Related]

  • 17. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.
    Nin JW, Ferreira I, Schalkwijk CG, Jorsal A, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD.
    Diabetologia; 2012 Sep; 55(9):2489-93. PubMed ID: 22752054
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial.
    Januzzi JL, Liu Y, Sattar N, Yavin Y, Pollock CA, Butler J, Jardine M, Heerspink HJL, Masson S, Breyer M, Hansen MK.
    Am Heart J; 2024 May; 271():38-47. PubMed ID: 38401646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.